Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ENDRA Life Sciences Inc. Director's Dealing 2018

Apr 19, 2018

35444_dirs_2018-04-19_9ba44e39-bbd9-4364-a1ef-1b410d38bb1b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2017-05-09

Reporting Person: Longboard Capital Advisors, LLC (10% Owner)
Reporting Person: Conrad Brett (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, $0.0001 par value 218899 Indirect
Common Stock, $0.0001 par value 210538 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrants $20.03 2020-05-29 Common Stock (12488) Indirect
Warrants $6.25 2022-05-12 Common Stock (210538) Indirect

Footnotes

F1: Longboard Capital Advisors, LLC is the General Partner of Blue Earth Fund, LP. Blue Earth Fund, LP owns 218,899 shares of Common Stock and 12,488 Warrants to purchase Common Stock in ENDRA Life Sciences, Inc.

F2: Longboard Capital Advisors, LLC is the Investment Manager of Grayboard Investments, Ltd. Grayboard Investments, Ltd. owns 210,538 shares of Common Stock and 210,538 Warrants to purchase Common Stock in ENDRA Life Sciences, Inc.